Evidence map›Paper›PMID 40790739›Full record

ArticleBMC health services research2025

Implementation strategies to integrate HIV and hypertension care in Kampala and Wakiso districts, Uganda: study protocol for a stepped wedge cluster randomized trial (PULESA-Uganda).

Chris T Longenecker, John Baptist Kiggundu, Florence Ayebare, Martin Muddu, James Kayima, Gerald Mutungi, Isaac Ssinabulya, Jeremy I Schwartz, Donna Spiegelman, Guangyu Tong and 8 more

Registry-linked trialAbstract readClinical Trial Protocol
In one paragraph

Article in BMC health services research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05609513 (PULESA Uganda), which is not on this map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05609513 nacompletednot on this map

PULESA Uganda: Strengthening the Blood Pressure Care and Treatment Cascade for Ugandans Living With HIV-ImpLEmentation Strategies to SAve Lives

TypeinterventionalSponsorInfectious Diseases Research Collaboration, UgandaRan2023 to 2025Enrolled87,421ConditionsHIV/AIDS, HypertensionArmsHTN-BASIC, HTN-PLUS
3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Chris T LongeneckerUniversity of Washington School of Medicine, Seattle, WA, USA. ctlongen@uw.edu.
John Baptist KiggunduInfectious Diseases Research Collaboration, Kampala, Uganda.
Florence AyebareInfectious Diseases Research Collaboration, Kampala, Uganda.
Martin MudduMakerere University, Kampala, Uganda.
James KayimaMakerere University, Kampala, Uganda.
Gerald MutungiUganda Ministry of Health, Kampala, Uganda.
Isaac SsinabulyaMakerere University, Kampala, Uganda.
Jeremy I SchwartzYale School of Medicine, New Haven, CT, USA.
Donna SpiegelmanYale School of Public Health, New Haven, CT, USA.
Guangyu TongYale School of Medicine, New Haven, CT, USA.
Rachel NugentDepartment of Global Health, University of Washington, 1159 Pacific Ave NE, Seattle, WA, 98195, USA.
Angela AifahNYU Grossman School of Medicine, New York, NY, USA.
Faith KagoyaInfectious Diseases Research Collaboration, Kampala, Uganda.
Drew B CameronYale School of Public Health, New Haven, CT, USA.
Brian HutchinsonRTI International, Seattle, WA, USA.
Moses R KamyaInfectious Diseases Research Collaboration, Kampala, Uganda.
Anne R KatahoireMakerere University, Kampala, Uganda.
Fred C SemitalaInfectious Diseases Research Collaboration, Kampala, Uganda.

Funding

PULESA-UGANDA-Strengthening the Blood Pressure Care and Treatment cascade for Ugandans living with HIV-ImpLEmentation Strategies to SAve livesUH3HL154501 · NHLBI · INFECTIOUS DISEASES RES COLLABORATION · PI LONGENECKER, CHRIS TODD, SEMITALA, FRED C · 2022 to 2024
$2.7M
NHLBI NIH HHS UH3 HL154501NHLBI NIH HHS UH3HL154501
6 · The paper itself

Abstract

backgroundHypertension (HTN) is the leading cause of cardiovascular morbidity and mortality among people living with HIV (PLWH) in Africa, yet integration of hypertension treatment in HIV clinics is sub-optimal. Cost-effective strategies to implement evidence-based hypertension care for this population are urgently needed to preserve the life-expectancy gains of antiretroviral therapy.

methodsBuilding on insights gained from a comprehensive mixed-methods formative assessment, we used a human-centered design approach to develop a multi-component HIV-HTN integration (HTN-PLUS) strategy. In a stepped-wedge cluster randomized trial, we are assessing the effectiveness, costs, and implementation of HTN-PLUS as well as a less resource intensive strategy of providing HTN medication and blood pressure cuffs (HTN-BASIC) free of charge to clinics. The trial is being conducted in 16 public and private not-for-profit HIV clinics in Kampala and Wakiso districts in Uganda. The co-primary effectiveness outcomes are population BP control (screened and documented BP < 140/90 mmHg) and HTN patient BP control [BP < 140/90 mmHg among PLWH with HTN]. The trial is designed to have > 80% power to detect a 12%-point increase in both outcomes compared to the pre-implementation control period across a range of scenarios of baseline hypertension prevalence and temporal improvements in the control period. At two pre-specified time points, we are conducting a Learn-As-You-Go optimization analysis and will adapt the HTN-PLUS strategy accordingly. To assess implementation outcomes, we have enrolled a prospective longitudinal mixed-methods cohort study of clinic health workers and PLWH with HTN. An extensive economic evaluation will include time and motion studies, facility-based costing, and out-of-pocket cost surveys to determine costs and cost-effectiveness from a societal perspective. DISCUSSION: Innovative implementation strategies to integrate evidence-based hypertension care for PLWH in Africa must be informed by the health workers and PLWH who are cared for across diverse HIV clinics. These clinics currently provide high quality HIV care as evidenced by high rates of HIV viral suppression but often lack the knowledge, skills and resources to provide HTN care. Funders and policymakers critically need to know both the effectiveness and costs to scale these strategies and potentially expand them to include other non-AIDS comorbidities.

trial registrationClinicalTrials.gov NCT05609513. Registered on November 11, 2022.

Indexed as

Delivery of Health Care, IntegratedHIV InfectionsHypertensionAntihypertensive AgentsCost-Benefit AnalysisHumansRandomized Controlled Trials as TopicUgandaAntihypertensive AgentsAfricaCluster randomized trialHIVHypertensionIntegrated care

Identifiers

PMID40790739
PMCPMC12341278

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.